IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIARI, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 833
EU - Europa 566
AS - Asia 555
SA - Sud America 84
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 814
SG - Singapore 233
IT - Italia 149
IE - Irlanda 125
CN - Cina 111
VN - Vietnam 81
HK - Hong Kong 74
BR - Brasile 70
DE - Germania 67
RU - Federazione Russa 53
FI - Finlandia 33
FR - Francia 29
RO - Romania 28
UA - Ucraina 21
GB - Regno Unito 17
CA - Canada 15
KR - Corea 14
IN - India 11
PL - Polonia 11
SE - Svezia 10
CH - Svizzera 5
EC - Ecuador 5
IQ - Iraq 5
JP - Giappone 5
BD - Bangladesh 4
CL - Cile 4
LT - Lituania 4
MX - Messico 4
TR - Turchia 4
ZA - Sudafrica 4
AT - Austria 3
ES - Italia 3
MA - Marocco 3
BE - Belgio 2
EU - Europa 2
JO - Giordania 2
NL - Olanda 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
EG - Egitto 1
GR - Grecia 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.050
Salva come PNG Salva come JPEG
Città #
Chandler 164
Singapore 162
Dublin 125
Hong Kong 74
Perugia 66
San Mateo 66
Ashburn 50
Dong Ket 44
Boardman 35
Beijing 34
Santa Clara 34
Altamura 33
Bucharest 28
Munich 28
Medford 24
Princeton 24
Lawrence 23
Houston 20
Helsinki 17
Ho Chi Minh City 17
Los Angeles 17
Moscow 16
Seoul 14
Andover 13
Wilmington 13
Jacksonville 10
New York 10
Nuremberg 10
Redmond 10
San Paolo di Civitate 9
Ann Arbor 8
Stockholm 8
Warsaw 8
Frankfurt am Main 7
São Paulo 7
Des Moines 6
Falkenstein 6
Hanoi 6
Saint Petersburg 6
The Dalles 6
Turku 6
Brooklyn 5
Calgary 5
Denver 5
Ottawa 5
Tokyo 5
Curitiba 4
Erbil 4
Nanjing 4
Phoenix 4
Poplar 4
Rio de Janeiro 4
Seattle 4
Bắc Ninh 3
Chennai 3
Columbus 3
Dallas 3
Guayaquil 3
Johannesburg 3
Manassas 3
New Delhi 3
Norwalk 3
Orem 3
Piscataway 3
Redwood City 3
Rome 3
San Francisco 3
Amman 2
Atlanta 2
Boston 2
Brussels 2
Hefei 2
Kansas City 2
Londrina 2
Manchester 2
Mexico City 2
Montreal 2
Mumbai 2
Pietralunga 2
Piracicaba 2
Torgiano 2
Vilnius 2
Almaty 1
Alto Alegre do Maranhão 1
Ankara 1
Araraquara 1
Araruama 1
Augusta 1
Azcapotzalco 1
Baghdad 1
Baku 1
Banja Luka 1
Baoding 1
Barreira 1
Belo Horizonte 1
Bexley 1
Boksburg 1
Bologna 1
Brasília 1
Caaguazú 1
Totale 1.407
Salva come PNG Salva come JPEG
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 178
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 110
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 110
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 103
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 99
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 92
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 91
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 89
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence 87
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer 82
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 82
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications 78
Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations 77
Osimertinib 77
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 76
How might treatment of ALK-positive non-small cell lung cancer change in the near future? 76
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 74
Texture Analysis on [18F]FDG PET/CT in Non-Small-Cell Lung Cancer: Correlations Between PET Features, CT Features, and Histological Types 74
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? 73
Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol 72
MiRNAs and resistance to EGFRâ€"TKIs in EGFR-mutant non-small cell lung cancer: Beyond 'traditional mechanisms' of resistance 69
Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland 66
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence 63
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice 61
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 40
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression 34
Totale 2.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 0 4 4 3 4 0 4 44
2021/2022251 1 47 2 4 1 2 2 66 30 21 34 41
2022/2023482 26 109 5 39 37 42 0 30 175 0 15 4
2023/2024192 11 12 9 8 0 2 55 1 8 4 43 39
2024/2025373 10 29 41 7 39 24 9 35 68 22 57 32
2025/2026519 58 63 46 126 158 68 0 0 0 0 0 0
Totale 2.133